1. DOP007 Efficacy of vedolizumab induction therapy on clinical and endoscopic activity in patients with anti-tumour necrosis factor alpha-resistant inflammatory bowel disease. (16th January 2018) Authors: Bor, R; Klaudia, F; Miheller, P; Palatka, K; Szamosi, T; Vincze, Á; Rutka, M; Szántó, K; Bálint, A; Szepes, Z; Nagy, F; Milassin, Á; Fábián, A; Csontos, Á; Golovics, P; Lakner, L; Müllner, K; Papp, M; Salamon, Á; Sarang, K Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S034 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P352 Ustekinumab is associated with superior treatment persistence compared to vedolizumab in Crohn's disease patients who failed to anti-TNF therapy: results from a Hungarian cohort study. (21st January 2022) Authors: Bacsur, P; Resál, T; Miheller, P; Szamosi, T; Schäfer, E; Sarlós, P; Iliás, Á; Szántó, K J; Rutka, M; Bálint, A; Fábián, A; Bor, R; Zoltán, S; Matuz, M; Molnár, T; Farkas, K Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P444 COVID-19 risk factors, infection course and vaccination among patients with inflammatory bowel disease based on a Hungarian cohort. (21st January 2022) Authors: Farkas, K; Matuz, M; Kata, D; Földesi, I; Resál, T; Bacsur, P; Szántó, K; Kolarovszki-Erdei, D; Rutka, M; Fábián, A; Bor, R; Szepes, Z; Sarlós, P; Miheller, P; Zacháry, A; Molnár, T Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P490 Patients with inflammatory bowel disease should be vaccinated against pneumococcus and influenza despite immunosuppressive therapy. (21st January 2022) Authors: Dohos, D; Müller, K E; Sipos, Z; Kiss, S; Dembrovszky, F; Kovács, N; Solymár, M; Erőss, B; Hegyi, P; Sarlós, P Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P534 IBD-related malignancies observed in 2015–2018: 4 years' results from the prospective nationwide Hungarian registry. (25th January 2019) Authors: Milassin, A; Rutka, M; Farkas, K; Bálint, A; Bor, R; Fábián, A; Szepes, Z; Szamosi, T; Szántó, K; Miheller, P; Barta, Z; Banai, J; Kovács, Á; Salamon, Á; Lakatos, L; Lakner, L; Palatka, K; Papp, M; Schafer, E; Novák, J Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P605 Real life efficacy of tofacitinib in different situation in ulcerative colitis: a retrospective worldwide multicentre collaborative study. (30th January 2023) Authors: Resál, T; Bacsur, P; Bor, R; Bálint, A; Katsanos, K; Michalopoylos, G; Ribaldone, D G; Attauabi, M; Mirabella, Z; Yanai, H; Bezzio, C; Castiglione, F; Bar-Gil Shitrit, A; Pugliese, D; Lakatos, P L; Savarino, E; Lukáš, M; Franko, M; Chashkova, E; Molander, P Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P797 Self-reported efficacy and safety of infliximab and adalimumab biosimilars after non-medical switch in patients with Inflammatory Bowel Disease: Results of a multicenter survey. (30th January 2023) Authors: Bikar, A; Farkas, N; Resál, T; Szepes, Z; Klaudia, F; Vincze, Á; Miheller, P; Molnár, T; Sarlós, P Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i928 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗